Clinical Trial Update: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Monotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the addition of aleglitazar to metformin in adults with type 2 diabetes inadequately controlled on metformin monotherapy has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aleglitazar (Aleglitazar)
• metformin (metformin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: COMPLETED